Discover 1,443 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,443
Active & Responsive
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
for
Non-small Cell Lung Cancer
Location: Seattle WA, Reno NV, Sacramento CA, Billings MT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07513376
Phase 3, Recruiting
Active & Responsive
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
for
Primary Myelofibrosis (PMF),
Location: Seattle WA, Denver CO, Fargo ND, Dallas TX, Chicago IL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07357727
Phase 3, Recruiting
Active & Responsive
A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT07078604
Phase 2, Recruiting
Active & Responsive
[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT06502691
Phase 1, Phase 2, Recruiting
Active & Responsive
IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence
for
Fallopian Tube Carcinoma, Ovarian Carcinoma,
Location: Seattle WA
Sponsor: University of Washington
Sex: Female
Age: 18+
Code: NCT07495124
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT07112053
Phase 2, Recruiting
Active & Responsive
FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia
for
Recurrent Childhood Acute Myeloid Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 0 - 6
Code: NCT06609928
Phase 1, Recruiting
Active & Responsive
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)